# Efficacy and safety of PD-L1 inhibitors versus PD-1 inhibitors in first-line treatment with chemotherapy for extensive-stage small-cell lung cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-pd-l1-inhibitors-versus-pd-1-inhibitors-in-first-line/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hui Yu,Ping Chen,Xiuyu Cai,Chen Chen,Xuanye Zhang,Lina He,Yixin Zhou,Shaodong Hong,Bei Zhang |
| Citations | 53 |
| DOI | 10.1007/s00262-021-03017-z |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/10992902 |
| OpenAlex ID | https://openalex.org/W3183217190 |
| PMID | 34297160 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Bei Zhang](https://scholariq.org/researchers/bei-zhang/)

## Paper primary topic

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Paper topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.